Brexit – medicines regulation outside the EU
As the Brexit transition period has now ended, the team at Boyds is continuing to support clients with the new guidance and regulations.
Furthermore, our Dublin office provides the foothold in Europe to ensure our clients can continue to benefit from access to the European Medicines Agency.
As the picture continues to evolve, we will bring you the latest updates from the regulatory authorities and post updates on this page. We also produce a monthly Regulatory Intelligence Digest (latest copies can be found below) and you can follow us on twitter @boydconsultants to keep up to date with the latest guidance and advice.
Get in touch to speak to the member of the team.